{"version":"1.0","type":"link","title":"Zamtocabtagene autoleucel in relapsed/refractory B-NHL: 5-year follow-up of a CD20/19 tandem CAR T-cell phase 1 trial.","author_name":"Balke-Want H 외","author_url":"https://prs-insight.online/author/Balke-Want%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/158694","thumbnail_width":1200,"thumbnail_height":630}